ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Inc (ACAD)

16.95
-0.42
(-2.42%)
Closed December 27 4:00PM
16.80
-0.15
( -0.88% )
Pre Market: 9:20AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 136.49M118.46M165.24M211.7M231.04M205.83M241.96M250.4M
Operating Income -46.06M-53.58M3.04M-57.78M34.94M15.21M30.44M31.64M
Pre Tax Income -40.89M-44.94M6.34M-52.14M39.7M21M37.18M38.81M
Net Income -41.73M-43.02M1.11M-65.18M45.8M16.56M33.39M32.77M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -46.06M-53.58M3.04M-52.67M34.94M15.5M30.82M32.22M
EBITDA -45.57M-53.16M4.8M-56.05M36.58M20.74M33.01M34.21M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 17.33M124.9M223.81M339.08M441.76M484.15M517.24M726.44M
Operating Income -272.82M-292.41M-247.44M-246.55M-286.59M-170.44M-223.6M-73.38M
Pre Tax Income -270.05M-288.28M-243.94M-234.38M-280.97M-167.52M-213.44M-51.04M
Net Income -271.39M-289.4M-245.19M-235.26M-281.58M-167.87M-215.98M-61.29M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.236-2.326-1.704-1.515-1.764-1.043-1.333-0.373
EBIT -272.82M-292.41M-247.44M-246.55M-286.59M-170.44M-223.6M-73.38M
EBITDA -270.99M-289.7M-244.44M-243.78M-283.65M-167.1M-221.57M-67.83M